Zuellig Pharma takes action vs plastic waste

Leading healthcare solutions company Zuellig Pharma continues its journey toward sustainability as it sealed a partnership with Plastic Credit Exchange (PCX) to ensure compliance with the Extended Producers Responsibility Act of 2022 (EPR Law).

The EPR Law requires obliged enterprises to recover and divert up to 80% of their plastic packaging waste by 2028.

PCX is a Producers Responsibility Organization that works to mobilize enterprises and businesses to take responsibility for their plastic footprint by providing comprehensive solution sets. Upon signing of the agreement, PCX included Zuellig Pharma in its membership roster and reported to the Department of Environment and Natural Resources (DENR) as required by the law.

The solution sets from PCX follow the hierarchy of plastic reduction, reuse, recycling, and offsetting, with the ultimate goal of contributing to the overall reduction of plastic waste and making sure it feeds the circular economy.

Among the services that will be provided by PCX to Zuellig Pharma are the registration of the plastic packaging footprint, the recovery and diversion programs, and plastic offsetting services for 2023.

Zuellig Pharma will work together with its clients, as the market authorization holder, to ensure accurate reporting and compliance with the law.

This collaboration with PCX is part of Zuellig Pharma’s commitment to ensure environmental sustainability in all areas of its operations.

“The partnership with PCX is important for us, as we work towards reducing our impact on the environment across our operations and supply chains, specifically with plastic waste,” said Jannette Jakosalem, Market Managing Director of Zuellig Pharma Philippines.

“This is part of our commitment to build a healthier and more sustainable future in the country and for all in Asia,” she added.

Just last month, Zuellig Pharma became the first and only organization in APAC and one of two companies worldwide in the Road Transport activity group to make it to the A-List for Climate Change by CDP. Zuellig Pharma was also awarded the Platinum medal from EcoVadis, the world’s most trusted provider of business sustainability ratings, for the third consecutive year in 2023.

Recently, Zuellig Pharma signed a power supply agreement with ACEN Renewable Energy Solutions (ACEN RES), the retail electricity arm of ACEN, to supply 100% renewable energy to power its two major distribution facilities in the Philippines – the Santa Rosa Distribution Center and Canlubang Distribution Center.

With the shift to using 100% renewable energy from ACEN, the distribution centers combined will reduce carbon dioxide (CO2) emissions by 10,600 tons each year.